Clinical Trials Browser

INDUSTRY × Uterine Cervical Neoplasms × Lapatinib × Clear all

NCT00430781 2015-05-08

Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer

Phase 2 Completed

228 enrolled 21 charts

Uterine Cervical Neoplasms, Neoplasms, Recurrence